Evidence map›Paper›PMID 41553638›Full record

ArticleHealth economics review2026

Catastrophic and impoverishing health expenditures in fragmented public health systems: lessons from Mexico, 2000-2022.

Diego Cerecero-García, Octavio Gómez-Dantés, Thomas Hone, Carlos Pineda-Antúnez, Alejandro Mohar-Betancourt, Laura Flamand, Edson Serván-Mori

Abstract read
In one paragraph

Article in Health economics review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Diego Cerecero-GarcíaCentre for Health Systems Research, the National Institute of Public Health, Avenida Universidad 655, Colonia Santa María Ahuacatitlán, Cuernavaca, Morelos, 62100, Mexico.
Octavio Gómez-DantésCentre for Health Systems Research, the National Institute of Public Health, Avenida Universidad 655, Colonia Santa María Ahuacatitlán, Cuernavaca, Morelos, 62100, Mexico.
Thomas HoneDepartment of Primary Care and Public Health, Public Health Policy Evaluation Unit, School of Public Health, Imperial College London, London, UK.
Carlos Pineda-AntúnezCentre for Health Systems Research, the National Institute of Public Health, Avenida Universidad 655, Colonia Santa María Ahuacatitlán, Cuernavaca, Morelos, 62100, Mexico.
Alejandro Mohar-BetancourtEpidemiology and Biomedical Cancer Research Unit, National Cancer Institute, and Biomedical Research Institute, National Autonomous University of Mexico, Mexico City, Mexico.
Laura FlamandCentre for International Studies, El Colegio de Mexico, Mexico City, Mexico.
Edson Serván-MoriCentre for Health Systems Research, the National Institute of Public Health, Avenida Universidad 655, Colonia Santa María Ahuacatitlán, Cuernavaca, Morelos, 62100, Mexico. eservan@insp.mx.

Funding

NIHR GHPSR researcher-led grant, UK Government NIHR150067
6 · The paper itself

Abstract

backgroundUniversal Health Coverage (UHC) requires that all individuals access comprehensive health services without facing financial hardship. Fragmented health systems, characterised by multiple uncoordinated financing schemes, can weaken financial risk protection and disproportionately expose vulnerable populations to out-of-pocket expenditures (OOP). Evidence on how fragmentation affects financial protection in Latin America is limited. This study examines the long-term trends in catastrophic, impoverishing, and excessive health expenditures in Mexico’s fragmented public health system.

methodsWe analysed 470,104 households from the Mexican National Household Income and Expenditure Survey (ENIGH, 2000–2022), corresponding to an estimated 341.3 million household-wave observations nationally. Financial hardship was measured using standard indicators: catastrophic health expenditure (CHE), impoverishing health expenditure (IHE), and excessive health expenditure (EHE). Descriptive results used a more granular insurance breakdown, whereas the main analyses grouped households into four main public insurance categories: uninsured, Seguro Popular/INSABI, social security, and mixed public coverage. Heckprobit models estimated adjusted probabilities of financial hardship, accounting for selection among households with positive health expenditure. Analyses incorporated the complex survey design and expansion factors, and sensitivity analyses used alternative thresholds for CHE and EHE.

findingsFinancial protection improved for most households between 2000 and 2014, particularly among Seguro Popular affiliates. After 2020, following the replacement of this public insurance scheme with INSABI, protection deteriorated, with CHE and EHE reaching their highest levels among mixed insurance households by 2022. Social security households consistently experienced the lowest financial burden, while uninsured and INSABI-affiliated households faced substantially higher risk. Increased use of private healthcare, especially for medicines, contributed to rising OOP. Sensitivity analyses confirmed these trends.

conclusionFragmentation in Mexico’s public health system has intensified inequalities in financial protection. The coexistence of multiple uncoordinated insurance schemes has failed to protect households from economic hardship, particularly those in the informal sector. Achieving meaningful UHC will require integrated financing reforms that standardise benefits, reduce administrative complexity, and address persistent gaps in service provision.

Indexed as

Catastrophic health expendituresFinancial protection in healthFragmentationImpoverishing health expendituresMexicoUniversal health coverage

Identifiers

PMID41553638
PMCPMC12924604

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.